Oncolytic virotherapy in veterinary medicine: current status and future prospects for canine patients

被引:35
|
作者
Patil, Sandeep S. [1 ]
Gentschev, Ivaylo [1 ,2 ]
Nolte, Ingo [3 ]
Ogilvie, Gregory [4 ,5 ]
Szalay, Aladar A. [1 ,2 ,5 ,6 ,7 ]
机构
[1] Univ Wurzburg, Dept Biochem, D-97074 Wurzburg, Germany
[2] Genelux Corp, San Diego Sci Ctr, San Diego, CA USA
[3] Univ Vet Med, Small Anim Clin, D-30173 Hannover, Germany
[4] Calif Vet Specialists, Angel Care Canc Ctr, Carlsbad, CA 92008 USA
[5] Univ Calif San Diego, Dept Radiat Oncol, Moores Canc Ctr, La Jolla, CA 92093 USA
[6] Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, D-97078 Wurzburg, Germany
[7] Univ Wurzburg, Inst Mol Infect Biol, D-97078 Wurzburg, Germany
关键词
cancer; canine cancer therapy; oncolytic virus; oncolysis; target molecule; combination therapy; ENDOTHELIAL GROWTH-FACTOR; REPLICATION-COMPETENT ADENOVIRUS; THYMIDINE KINASE-ACTIVITY; MESENCHYMAL STEM-CELLS; VACCINIA VIRUS; ANTITUMOR-ACTIVITY; IMMUNOHISTOCHEMICAL EXPRESSION; INTRATUMORAL SPREAD; MALIGNANT-LYMPHOMA; SYSTEMIC DELIVERY;
D O I
10.1186/1479-5876-10-3
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Oncolytic viruses refer to those that are able to eliminate malignancies by direct targeting and lysis of cancer cells, leaving non-cancerous tissues unharmed. Several oncolytic viruses including adenovirus strains, canine distemper virus and vaccinia virus strains have been used for canine cancer therapy in preclinical studies. However, in contrast to human studies, clinical trials with oncolytic viruses for canine cancer patients have not been reported. An 'ideal' virus has yet to be identified. This review is focused on the prospective use of oncolytic viruses in the treatment of canine tumors - a knowledge that will undoubtedly contribute to the development of oncolytic viral agents for canine cancer therapy in the future.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Oncolytic virotherapy in veterinary medicine: current status and future prospects for canine patients
    Sandeep S Patil
    Ivaylo Gentschev
    Ingo Nolte
    Gregory Ogilvie
    Aladar A Szalay
    Journal of Translational Medicine, 10
  • [2] Oncolytic virotherapy for pediatric malignancies: future prospects
    Waters, Alicia M.
    Friedman, Gregory K.
    Ring, Eric K.
    Beierle, Elizabeth A.
    ONCOLYTIC VIROTHERAPY, 2016, 5 : 73 - 80
  • [3] Antifungal Nano-Therapy in Veterinary Medicine: Current Status and Future Prospects
    Alghuthaymi, Mousa A.
    Hassan, Atef A.
    Kalia, Anu
    El Ahl, Rasha M. H. Sayed
    El Hamaky, Ahmed A. M.
    Oleksak, Patrik
    Kuca, Kamil
    Abd-Elsalam, Kamel A.
    JOURNAL OF FUNGI, 2021, 7 (07)
  • [4] Veterinary pharmacology: history, current status and future prospects
    Lees, P.
    Fink-Gremmels, J.
    Toutain, P. L.
    JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2013, 36 (02) : 105 - 115
  • [5] The current status and future prospects of precision medicine
    Pasic, Maria D.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2020, 58 (09) : 1423 - 1425
  • [6] Current Status and Challenges of Oncolytic Virotherapy for the Treatment of Glioblastoma
    Webb, Mason J.
    Sener, Ugur
    Vile, Richard G.
    PHARMACEUTICALS, 2023, 16 (06)
  • [7] Oncolytic Virotherapy for Malignant Tumor: Current Clinical Status
    Zhang, Yuhui
    Liu, Zhuoming
    CURRENT PHARMACEUTICAL DESIGN, 2019, 25 (40) : 4251 - 4263
  • [8] Clinical Trials with Oncolytic Measles Virus: Current Status and Future Prospects
    Msaouel, Pavlos
    Opyrchal, Mateusz
    Dispenzieri, Angela
    Peng, Kah Whye
    Federspiel, Mark J.
    Russell, Stephen J.
    Galanis, Evanthia
    CURRENT CANCER DRUG TARGETS, 2018, 18 (02) : 177 - 187
  • [10] Techniques of reproduction medicine. Current status and future prospects
    Ludwig, M
    GYNAKOLOGE, 2002, 35 (12): : 1253 - 1264